{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:21Z","timestamp":1786998321943,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xphs.2023.09.012","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T01:09:23Z","timestamp":1695517763000},"page":"2991-3004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vaporized Hydrogen Peroxide Sterilization in the Production of Protein Therapeutics: Uptake and Effects on Product Quality"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-9835","authenticated-orcid":false,"given":"Michael","family":"Meleties","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5232-3361","authenticated-orcid":false,"given":"Bailey M.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Marcano-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amardeep S.","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Shameem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0001","first-page":"140","article-title":"Experience in the design and use of isolator systems for sterility testing","volume":"49","author":"Akers","year":"1995","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.xphs.2023.09.012_bib0002","series-title":"Sterilisation of Biomaterials and Medical Devices","first-page":"97","article-title":"5 - Non-traditional sterilization techniques for biomaterials and medical devices","author":"Lerouge","year":"2012"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0003","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/jam.14412","article-title":"Terminal sterilization of medical devices using vaporized hydrogen peroxide: a review of current methods and emerging opportunities","volume":"127","author":"McEvoy","year":"2019","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.xphs.2023.09.012_bib0004","series-title":"Advanced Aseptic Processing Technology","author":"Agalloco","year":"2010"},{"issue":"13","key":"10.1016\/j.xphs.2023.09.012_bib0005","article-title":"Sterilization of objects, products, and packaging surfaces and their characterization in different fields of industry: the status in 2020","volume":"218","author":"Jildeh","year":"2021","journal-title":"Phys Status Solidi (A)"},{"key":"10.1016\/j.xphs.2023.09.012_bib0006","doi-asserted-by":"crossref","unstructured":"Edwards LM, Childers RW. Hydrogen peroxide vapor sterilization: applications in the production environment. Aseptic Pharmaceutical Manufacturing II: Applications for the 1990s 2020, 415.","DOI":"10.1201\/9781003070467-15"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0007","first-page":"130","article-title":"Development of a sterilizing in-place application for a production machine using Vaporized Hydrogen Peroxide","volume":"58","author":"Mau","year":"2004","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0008","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.xphs.2018.09.029","article-title":"Impact of ethylene oxide sterilization of polymer-based prefilled syringes on chemical degradation of a model therapeutic protein during storage","volume":"108","author":"Funatsu","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0009","series-title":"Challenges in Protein Product Development","first-page":"385","article-title":"Line sterilization considerations and VHP","author":"Grauschopf","year":"2018"},{"issue":"5, Supplement","key":"10.1016\/j.xphs.2023.09.012_bib0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajic.2012.11.005","article-title":"Disinfection and sterilization: an overview","volume":"41","author":"Rutala","year":"2013","journal-title":"Am J Infect Control"},{"issue":"6","key":"10.1016\/j.xphs.2023.09.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130043","article-title":"Nitrogen dioxide sterilization in low-resource environments: a feasibility study","volume":"10","author":"Shomali","year":"2015","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.012_bib0012","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1021\/jp0677703","article-title":"N-Nitrosation of amines by NO2 and NO:\u2009 a theoretical study","volume":"111","author":"Zhao","year":"2007","journal-title":"J Phys Chem A"},{"issue":"5, Supplement","key":"10.1016\/j.xphs.2023.09.012_bib0013","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ajic.2012.12.007","article-title":"New technologies and trends in sterilization and disinfection","volume":"41","author":"Schneider","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.xphs.2023.09.012_bib0014","series-title":"General Hospital and Personal Use Devices Panel","first-page":"248","year":"2019"},{"key":"10.1016\/j.xphs.2023.09.012_bib0015","unstructured":"Oakley T. Drug delivery device trends for 2022."},{"key":"10.1016\/j.xphs.2023.09.012_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122867","article-title":"Sterilisation of biopharmaceuticals: effect of gamma irradiation, e-beam irradiation and nitrogen dioxide on human insulin","volume":"636","author":"Van den Bergh","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.09.012_bib0017","series-title":"FDA Meeting: NO2 Technology as EtO Alternative","year":"2019"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0018","first-page":"286","article-title":"Development and quantification of H2O2 decontamination cycles","volume":"54","author":"Sigwarth","year":"2000","journal-title":"PDA J Pharm Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0019","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12247-011-9114-6","article-title":"Quantifying absorption effects during hydrogen peroxide decontamination","volume":"6","author":"Radl","year":"2011","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.xphs.2023.09.012_bib0020","unstructured":"OSHA Annotated Table Z-1. https:\/\/www.osha.gov\/annotated-pels\/table-z-1 (accessed Feb. 9, 2023)."},{"issue":"10","key":"10.1016\/j.xphs.2023.09.012_bib0021","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/jac\/dkq308","article-title":"Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms","volume":"65","author":"Finnegan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.xphs.2023.09.012_bib0022","series-title":"Points to Consider for Sensitivity to Oxidation by Peroxide","author":"Downey","year":"2020"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.22812","article-title":"Forced degradation of therapeutic proteins","volume":"101","author":"Hawe","year":"2012","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.09.012_bib0024","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1002\/jps.21746","article-title":"Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization","volume":"98","author":"Ji","year":"2009","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5731\/pdajpst.2019.009928","article-title":"Vapor-phase hydrogen peroxide uptake by silicone tubing and primary packaging components during protein drug product aseptic filling: impact of pretreatment and sterilization process","volume":"73","author":"Eisner","year":"2019","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0026","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5731\/pdajpst.2018.009431","article-title":"A Model of prefilled syringes exposure to vapor phase hydrogen peroxide (VPHP)","volume":"74","author":"Downey","year":"2020","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0027","first-page":"26","article-title":"Measuring hydrogen peroxide residuals and product exposure on isolator and rabs filling lines","volume":"4","author":"Hubbard","year":"2015","journal-title":"BioPharma Asia"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12247-011-9097-3","article-title":"Hydrogen peroxide vapor penetration into small cavities during low-temperature decontamination cycles","volume":"6","author":"Unger-Bimczok","year":"2011","journal-title":"J Pharm Innov"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12247-008-9027-1","article-title":"The influence of humidity, hydrogen peroxide concentration, and condensation on the inactivation of geobacillus stearothermophilus spores with hydrogen peroxide vapor","volume":"3","author":"Unger-Bimczok","year":"2008","journal-title":"J Pharm Innov"},{"issue":"8","key":"10.1016\/j.xphs.2023.09.012_bib0030","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.xphs.2020.04.012","article-title":"Towards an understanding of the adsorption of vaporized hydrogen peroxide (VHP) residues on glass vials after a vhp decontamination process using a miniaturized tool","volume":"109","author":"Kushwah","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0031","unstructured":"Haycocks NR, Goldschmidt NA, Thomsen U. Temperature & Humidity Requirements in Pharmaceutical Facilities 2021. https:\/\/ispe.org\/pharmaceutical-engineering\/september-october-2021\/temperature-humidity-requirements-pharmaceutical."},{"issue":"8","key":"10.1016\/j.xphs.2023.09.012_bib0032","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.xphs.2019.03.033","article-title":"The diffusion of hydrogen peroxide into the liquid product during filling operations inside vaporous hydrogen peroxide\u2013sterilized isolators can be predicted by a mechanistic model","volume":"108","author":"Vuylsteke","year":"2019","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0033","doi-asserted-by":"crossref","first-page":"348","DOI":"10.5731\/pdajpst.2017.008326","article-title":"Vapor phase hydrogen peroxide decontamination or sanitization of an isolator for aseptic filling of monoclonal antibody drug product-hydrogen peroxide uptake and impact on protein quality","volume":"72","author":"Hubbard","year":"2018","journal-title":"PDA J Pharm Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.xphs.2021.09.003","article-title":"Chemical-gas sterilization of external surface of polymer-based prefilled syringes and its effect on stability of model therapeutic protein","volume":"111","author":"Fujiwara","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2020.05.024","article-title":"Impact of H2O2 sorption by polymers on the duration of aeration in pharmaceutical decontamination","author":"Yabuta","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0036","doi-asserted-by":"crossref","DOI":"10.30802\/AALAS-JAALAS-19-000165","article-title":"Examination of material compatibilities with ionized and vaporized hydrogen peroxide decontamination","author":"Kimura","year":"2020","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0037","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10904-008-9205-0","article-title":"Gamma irradiation of silicones","volume":"18","author":"Palsule","year":"2008","journal-title":"J Inorg Organomet Polym Mater"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0038","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/pat.3854","article-title":"Effect of gamma-irradiation sterilization on the physical and mechanical properties of a hybrid wound dressing","volume":"28","author":"Mazor","year":"2017","journal-title":"Polym Adv Technol"},{"key":"10.1016\/j.xphs.2023.09.012_bib0039","series-title":"Points to Consider for the Aseptic Processing of Sterile Pharmaceutical Products in Isolators","first-page":"85","author":"Gapp","year":"2020"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0040","first-page":"511","article-title":"Kinetic modeling of methionine oxidation in monoclonal antibodies from hydrogen peroxide spiking studies","volume":"69","author":"Hui","year":"2015","journal-title":"PDA J Pharm Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0041","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ab.2004.07.037","article-title":"Complexities in horseradish peroxidase-catalyzed oxidation of dihydroxyphenoxazine derivatives: appropriate ranges for pH values and hydrogen peroxide concentrations in quantitative analysis","volume":"334","author":"Towne","year":"2004","journal-title":"Anal Biochem"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.012_bib0042","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.xphs.2020.07.012","article-title":"Method to determine syringe silicone oil layer heterogeneity and investigation of its impact on product particle counts","volume":"109","author":"Cua","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-021-01949-4","article-title":"Container closure and delivery considerations for intravitreal drug administration","volume":"22","author":"Parenky","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0044","first-page":"307","article-title":"The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation","volume":"10","author":"Cleland","year":"1993","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/bit.260480511","article-title":"Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization","volume":"48","author":"Li","year":"1995","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"10.1016\/j.xphs.2023.09.012_bib0046","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0731-7085(96)01721-9","article-title":"The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody","volume":"14","author":"Usami","year":"1996","journal-title":"J Pharm Biomed Anal"},{"issue":"28","key":"10.1016\/j.xphs.2023.09.012_bib0047","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1074\/jbc.M110.160440","article-title":"Chemical modifications in therapeutic protein aggregates generated under different stress conditions","volume":"286","author":"Luo","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.012_bib0048","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.xphs.2018.07.024","article-title":"Effect of peroxide- versus alkoxyl-induced chemical oxidation on the structure, stability, aggregation, and function of a therapeutic monoclonal antibody","volume":"107","author":"Shah","year":"2018","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0049","first-page":"121","article-title":"Oxidation of protein by vaporized sanitizing agents","volume":"58","author":"Wang","year":"2004","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0050","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.xphs.2018.01.002","article-title":"Prediction of the hydrogen peroxide\u2013induced methionine oxidation propensity in monoclonal antibodies","volume":"107","author":"Agrawal","year":"2018","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.09.012_bib0051","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/jps.20207","article-title":"A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals","volume":"93","author":"Chu","year":"2004","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2023.09.012_bib0052","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1023\/A:1025771421906","article-title":"Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation","volume":"20","author":"Chi","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2023.09.012_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2021.03.003","article-title":"Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations","volume":"173","author":"Thakral","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0054","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"Wang","year":"2000","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/bp070462h","article-title":"Current perspectives on stability of protein drug products during formulation, fill and finish operations","volume":"24","author":"Rathore","year":"2008","journal-title":"Biotechnol Prog"},{"issue":"6","key":"10.1016\/j.xphs.2023.09.012_bib0056","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.xphs.2016.03.034","article-title":"Hydrogen peroxide induced protein oxidation during storage and lyophilization process","volume":"105","author":"Cheng","year":"2016","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5731\/pdajpst.2018.009340","article-title":"Stability evaluation of hydrogen peroxide uptake samples from monoclonal antibody drug product aseptically filled in vapor phase hydrogen peroxide-sanitized barrier systems: a case study","volume":"73","author":"Eisner","year":"2019","journal-title":"PDA J Pharm Sci Technol"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0058","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2006.03.011","article-title":"Formulation and delivery issues for monoclonal antibody therapeutics","volume":"58","author":"Daugherty","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.012_bib0059","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1002\/jps.21696","article-title":"Measurement and decomposition kinetics of residual hydrogen peroxide in the presence of commonly used excipients and preservatives","volume":"98","author":"Towne","year":"2009","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2023.09.012_bib0060","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/jps.22597","article-title":"Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals","volume":"100","author":"Bee","year":"2011","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0061","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/jps.23931","article-title":"Impact of Residual Impurities and Contaminants on Protein Stability","volume":"103","author":"Wang","year":"2014","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0062","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1081\/PDT-120030247","article-title":"Antioxidant-accelerated oxidative degradation: a case study of transition metal ion catalyzed oxidation in formulation","volume":"9","author":"Hong","year":"2004","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0063","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.xphs.2022.09.011","article-title":"Residue-specific impact of EDTA and methionine on protein oxidation in biotherapeutics formulations using an integrated biotherapeutics drug product development workflow","volume":"112","author":"Thakkar","year":"2023","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0064","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0065","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0891-5849(01)00623-2","article-title":"The hydrogen peroxide\/copper ion system, but not other metal-catalyzed oxidation systems, produces protein-bound dityrosine","volume":"31","author":"Kato","year":"2001","journal-title":"Free Rad. Biol. Med."},{"issue":"7","key":"10.1016\/j.xphs.2023.09.012_bib0066","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/BJ20151227","article-title":"Protein oxidation and peroxidation","volume":"473","author":"Davies","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.xphs.2023.09.012_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2023.03.026","article-title":"The evolution of commercial antibody formulations","author":"Mieczkowski","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0068","unstructured":"Novel drug approvals for 2023. https:\/\/www.fda.gov\/drugs\/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products\/novel-drug-approvals-2023 (accessed August 15, 2023)."},{"key":"10.1016\/j.xphs.2023.09.012_bib0069","first-page":"19153","article-title":"GlaxoSmithKline intellectual property development Ltd. England; Announcement of the revocation of the biologics license for Blenrep. US Food and Drug Administration","volume":"88","author":"Roth","year":"2023","journal-title":"Fed Regist"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2023.09.012_bib0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijpharm.2018.10.008","article-title":"Polysorbate degradation in biotherapeutic formulations: identification and discussion of current root causes","volume":"552","author":"Dwivedi","year":"2018","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.09.012_bib0071","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.xphs.2019.01.006","article-title":"Factors influencing polysorbate's sensitivity against enzymatic hydrolysis and oxidative degradation","volume":"108","author":"Kranz","year":"2019","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0072","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/antiox9050441","article-title":"Protein formulations containing polysorbates: are metal chelators needed at all?","volume":"9","author":"Brov\u010d","year":"2020","journal-title":"Antioxidants"},{"issue":"9","key":"10.1016\/j.xphs.2023.09.012_bib0073","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/aps.2010.120","article-title":"Research and development of next generation of antibody-based therapeutics","volume":"31","author":"Li","year":"2010","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.012_bib0074","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.xphs.2019.05.031","article-title":"Considerations for the design of antibody-based therapeutics","volume":"109","author":"Goulet","year":"2020","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.xphs.2018.10.039","article-title":"Oxidation-induced destabilization of model antibody-drug conjugates","volume":"108","author":"Buecheler","year":"2019","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.012_bib0076","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/jphp.12873","article-title":"High-throughput oxidation screen of antibody\u2013drug conjugates by analytical protein A chromatography following IdeS digest","volume":"70","author":"Buecheler","year":"2018","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"10.1016\/j.xphs.2023.09.012_bib0077","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1021\/acs.molpharmaceut.8b00177","article-title":"Impact of payload hydrophobicity on the stability of antibody\u2013drug conjugates","volume":"15","author":"Buecheler","year":"2018","journal-title":"Mol Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.012_bib0078","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/bc400439x","article-title":"Auristatin antibody drug conjugate physical instability and the role of drug payload","volume":"25","author":"Adem","year":"2014","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2023.09.012_bib0079","first-page":"11","article-title":"Forced degradation studies: an essential tool for the formulation development of vaccines","volume":"3","author":"Hasija","year":"2013","journal-title":"Vaccine: Dev Therapy"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.012_bib0080","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00018-010-0277-y","article-title":"Oxidative damage to RNA: mechanisms, consequences, and diseases","volume":"67","author":"Kong","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.xphs.2023.09.012_bib0081","series-title":"In Sensitivity of DNA and Nucleotides to Oxidation by Permanganate and Hydrogen Peroxide","first-page":"84","author":"Sagelsdorff","year":"1987"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0082","first-page":"101","article-title":"Review of disinfection and sterilization \u2013 back to the basics","volume":"50","author":"Yoo","year":"2018","journal-title":"IC"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.012_bib0083","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2307\/3577785","article-title":"Hydrogen peroxide-induced base damage in deoxyribonucleic acid","volume":"121","author":"Blakely","year":"1990","journal-title":"Radiat Res"},{"issue":"10","key":"10.1016\/j.xphs.2023.09.012_bib0084","doi-asserted-by":"crossref","first-page":"R2299","DOI":"10.1111\/1750-3841.13423","article-title":"Current knowledge about Oxysterols: a review","volume":"81","author":"Brzeska","year":"2016","journal-title":"J Food Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.012_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/17425247.2023.2162876","article-title":"Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out","volume":"20","author":"De","year":"2023","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.xphs.2023.09.012_bib0086","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2023.07.002","article-title":"The ice age \u2013 A review on formulation of Adeno-associated virus therapeutics","volume":"190","author":"Grossen","year":"2023","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2023.09.012_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-018-2554-7","article-title":"Pharmaceutical development of AAV-based gene therapy products for the eye","volume":"36","author":"Rodrigues","year":"2019","journal-title":"Pharm Res"},{"issue":"23\u201324","key":"10.1016\/j.xphs.2023.09.012_bib0088","first-page":"1501","article-title":"Optimized reversed-phase liquid chromatography\/mass spectrometry methods for intact protein analysis and peptide mapping of Adeno-associated virus proteins","volume":"32","year":"2021","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.xphs.2023.09.012_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114427","article-title":"Fast and efficient digestion of adeno associated virus (AAV) capsid proteins for liquid chromatography mass spectrometry (LC-MS) based peptide mapping and post translational modification analysis (PTMs)","volume":"207","author":"Guapo","year":"2022","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2023.09.012_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibtech.2023.04.002","article-title":"Challenges in scaling up AAV-based gene therapy manufacturing","author":"Jiang","year":"2023","journal-title":"Trends Biotechnol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:30Z","timestamp":1758361350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923003763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0022354923003763"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.09.012","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaporized Hydrogen Peroxide Sterilization in the Production of Protein Therapeutics: Uptake and Effects on Product Quality","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}